Molecular and genetic testing are essential tools in modern medicine, helping doctors understand disease at a deeper biological level. These tests analyze changes in genes and molecular pathways that influence how cancer develops, behaves, and responds to treatment. By looking beyond what can be seen on imaging or under the microscope, this approach allows care to be tailored to the unique characteristics of each patient.

At OncoClinic, molecular and genetic testing are central to our precision medicine strategy. We evaluate both tumor-specific genetic changes and, when appropriate, inherited (germline) genetic variations. Together, these insights help guide diagnosis, treatment decisions, prevention strategies, and long-term care for patients and their families.

Understanding the technology

Two main types of genetic testing help doctors understand cancer in different ways:

Tumor molecular testing

• Tumor molecular testing focuses on genetic changes that occur within cancer cells themselves
• These changes are not inherited but develop over time as cancer grows
• Identifying these alterations helps doctors understand what is driving the cancer and whether it may respond to targeted therapies, immunotherapy, or specific treatment combinations

Germline testing

• It evaluates genetic variants that are inherited and present in all cells of the body
• These inherited changes may increase a person’s risk of developing certain cancers and can also influence treatment choices
• Germline testing plays an important role in cancer prevention, early detection, and family counseling, helping relatives understand and manage potential shared risks

By combining tumor molecular analysis with germline testing when indicated, our specialists gain a comprehensive view of both the cancer’s biology and the patient’s underlying genetic risk

Why it matters

• Refine and confirm diagnosis by identifying specific cancer subtypes and genetic drivers
• Guide personalized treatment selection, including targeted therapies and immunotherapy
• Predict treatment response or resistance, improving clinical decision-making
• Avoid ineffective treatments, reducing unnecessary side effects
• Identify inherited cancer risk, supporting prevention and early detection strategies
• Provide informed guidance for family members who may share similar genetic risks
• Support long-term monitoring and follow-up, including detection of disease progression or recurrence

How this testing fits into patient care

• Molecular and genetic testing are used alongside imaging, pathology, and clinical evaluation to create a complete and accurate picture of each patient’s condition
• Depending on the clinical situation, testing may be performed on tumor tissue obtained through biopsy or surgery, or through blood-based testing
• Results are carefully interpreted by experienced specialists and, when appropriate, reviewed in multidisciplinary discussions to ensure findings are translated into meaningful, patient-centered care decisions
• When inherited risk is identified, genetic counseling and preventive guidance may be recommended to support patients and their families
• By integrating molecular and germline insights into every stage of care, OncoClinic delivers a precision medicine approach that goes beyond treating disease—focusing instead on treating the individual, protecting long-term health, and supporting families